RecruitingAdvanced Solid TumorsAdvanced Breast Cancer
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Eligible age
18+ yrs
Accepts
All genders
Locations
7 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Phase 1/2, open-label study of ETX-636 in participants with advanced solid tumors
Sponsor: Ensem Therapeutics
Where it's recruiting
California
Newport Beach · San Francisco
Connecticut
New Haven
Massachusetts
Boston
North Carolina
Huntersville
Texas
Houston · San Antonio
Virginia
Fairfax
Washington
Seattle
Source: ClinicalTrials.gov · NCT06993844 · last updated 2026-06-23